116 related articles for article (PubMed ID: 12820810)
21. Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.
Kearney BP; Sayre JR; Flaherty JF; Chen SS; Kaul S; Cheng AK
J Clin Pharmacol; 2005 Dec; 45(12):1360-7. PubMed ID: 16291710
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal study on mitochondrial effects of didanosine-tenofovir combination.
López S; Negredo E; Garrabou G; Puig J; Ruiz L; Sanjurjo E; Ramos X; Infante AB; Casademont J; Cardellach F; Clotet B; Miró O
AIDS Res Hum Retroviruses; 2006 Jan; 22(1):33-9. PubMed ID: 16438643
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
Hartman NR; Ahluwalia GS; Cooney DA; Mitsuya H; Kageyama S; Fridland A; Broder S; Johns DG
Mol Pharmacol; 1991 Jul; 40(1):118-24. PubMed ID: 1677450
[TBL] [Abstract][Full Text] [Related]
24. Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics.
Kearney BP; Flaherty JF; Shah J
Clin Pharmacokinet; 2004; 43(9):595-612. PubMed ID: 15217303
[TBL] [Abstract][Full Text] [Related]
25. Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies.
Negredo E; Bonjoch A; Paredes R; Puig J; Clotet B
Clin Infect Dis; 2005 Sep; 41(6):901-5. PubMed ID: 16107993
[TBL] [Abstract][Full Text] [Related]
26. The determination of human peripheral blood mononuclear cell counts using a genomic DNA standard and application in tenofovir diphosphate quantitation.
Xiao D; Ling KHJ; Tarnowski T; Majeed SR; Kearney B; Kolaris C; Zondlo S
Anal Biochem; 2019 Nov; 585():113399. PubMed ID: 31437427
[TBL] [Abstract][Full Text] [Related]
27. A strategy for liquid chromatography/tandem mass spectrometric assays of intracellular drugs: application to the validation of the triphosphorylated anabolite of antiretrovirals in peripheral blood mononuclear cells.
Becher F; Pruvost A; Gale J; Couerbe P; Goujard C; Boutet V; Ezan E; Grassi J; Benech H
J Mass Spectrom; 2003 Aug; 38(8):879-90. PubMed ID: 12938109
[TBL] [Abstract][Full Text] [Related]
28. Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cells.
Balzarini J; Van Herrewege Y; Vanham G
AIDS; 2002 Nov; 16(16):2159-63. PubMed ID: 12409737
[TBL] [Abstract][Full Text] [Related]
29. Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment.
Callens S; De Schacht C; Huyst V; Colebunders R
J Infect; 2003 Aug; 47(2):188-9. PubMed ID: 12860159
[No Abstract] [Full Text] [Related]
30. Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats.
Lebrecht D; Venhoff AC; Kirschner J; Wiech T; Venhoff N; Walker UA
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):258-63. PubMed ID: 19582894
[TBL] [Abstract][Full Text] [Related]
31. Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine.
Rollot F; Nazal EM; Chauvelot-Moachon L; Kélaïdi C; Daniel N; Saba M; Abad S; Blanche P
Clin Infect Dis; 2003 Dec; 37(12):e174-6. PubMed ID: 14689363
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitro.
Balestrieri E; Sciortino MT; Mastino A; Macchi B
Antiviral Res; 2005 Dec; 68(3):154-62. PubMed ID: 16271772
[TBL] [Abstract][Full Text] [Related]
33. Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients.
Pruvost A; Negredo E; Benech H; Theodoro F; Puig J; Grau E; García E; Moltó J; Grassi J; Clotet B
Antimicrob Agents Chemother; 2005 May; 49(5):1907-14. PubMed ID: 15855513
[TBL] [Abstract][Full Text] [Related]
34. Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus.
Delaney WE; Ray AS; Yang H; Qi X; Xiong S; Zhu Y; Miller MD
Antimicrob Agents Chemother; 2006 Jul; 50(7):2471-7. PubMed ID: 16801428
[TBL] [Abstract][Full Text] [Related]
35. Selectivity of kinases on the activation of tenofovir, an anti-HIV agent.
Varga A; Gráczer E; Chaloin L; Liliom K; Závodszky P; Lionne C; Vas M
Eur J Pharm Sci; 2013 Jan; 48(1-2):307-15. PubMed ID: 23201309
[TBL] [Abstract][Full Text] [Related]
36. High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir.
León A; Mallolas J; Martinez E; De Lazzari E; Pumarola T; Larrousse M; Milincovic A; Lonca M; Blanco JL; Laguno M; Biglia A; Gatell JM
AIDS; 2005 Oct; 19(15):1695-7. PubMed ID: 16184042
[TBL] [Abstract][Full Text] [Related]
37. Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon*.
Birkus G; Hájek M; Kramata P; Votruba I; Holý A; Otová B
Antimicrob Agents Chemother; 2002 May; 46(5):1610-3. PubMed ID: 11959615
[TBL] [Abstract][Full Text] [Related]
38. Early virologic failure in HIV-1 infected subjects on didanosine/tenofovir/efavirenz: 12-week results from a randomized trial.
Maitland D; Moyle G; Hand J; Mandalia S; Boffito M; Nelson M; Gazzard B
AIDS; 2005 Jul; 19(11):1183-8. PubMed ID: 15990571
[TBL] [Abstract][Full Text] [Related]
39. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
[TBL] [Abstract][Full Text] [Related]
40. Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients.
Taburet AM; Piketty C; Chazallon C; Vincent I; Gérard L; Calvez V; Clavel F; Aboulker JP; Girard PM
Antimicrob Agents Chemother; 2004 Jun; 48(6):2091-6. PubMed ID: 15155205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
